Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Injections for Trigeminal Neuralgia
NCT04505280Completed
- Sponsor
- Kartal Dr. Lütfi Kırdar City Hospital
- Start
- Jul 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine in trigeminal neuralgia (TN) (2 arms), sponsored by Kartal Dr. Lütfi Kırdar City Hospital. Primary endpoints: Efficacy on pain severity at 3 months and Efficacy on pain frequency at 3 months. Started Jul 2020; status: completed.
02
Drugs
lidocaine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT04505280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505280.